MHS gets bad news; Big pharma seeks to deal with approaching patent cliff;

> The second Medicare Health Support report has been delivered to Congress, and the news is not good: the program didn't achieve much improvement, while costing more than it saved. PDF

> Big pharma is taking a varied approach to dealing with the large number of patents that will expire in 2011. FiercePharma

> A new test can look at the genetic code of a hepatitis C variant and tell doctors whether the patient will respond to available drugs. FierceBioResearcher

> Some California health foundations and think tanks are turning themselves into lobbyists to try to finally get results in healthcare reform. Article

And Finally... This philosophy competition asks tough questions. Article